These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15151762)

  • 1. [Inhibition of momordica anti-HIV protein of MAP30 on HBeAg expression by laser scanning confocal microscopy].
    Wang JP; Wang LX; Sun YT; Bai XF; Li JG; Chen WH; Sun L; Luo KX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Mar; 19(2):183-4. PubMed ID: 15151762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition on Hepatitis B virus in vitro of recombinant MAP30 from bitter melon.
    Fan JM; Zhang Q; Xu J; Zhu S; Ke T; Gao DF; Xu YB
    Mol Biol Rep; 2009 Feb; 36(2):381-8. PubMed ID: 18058255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiviral agents, MAP30 and GAP31, are not toxic to human spermatozoa and may be useful in preventing the sexual transmission of human immunodeficiency virus type 1.
    Schreiber CA; Wan L; Sun Y; Lu L; Krey LC; Lee-Huang S
    Fertil Steril; 1999 Oct; 72(4):686-90. PubMed ID: 10521111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Α-MMC and MAP30, two ribosome-inactivating proteins extracted from Momordica charantia, induce cell cycle arrest and apoptosis in A549 human lung carcinoma cells.
    Fan X; He L; Meng Y; Li G; Li L; Meng Y
    Mol Med Rep; 2015 May; 11(5):3553-8. PubMed ID: 25573293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of an antitumor and antivirus agent: chemical modification of α-MMC and MAP30 from Momordica Charantia L. with covalent conjugation of polyethyelene glycol.
    Meng Y; Liu S; Li J; Meng Y; Zhao X
    Int J Nanomedicine; 2012; 7():3133-42. PubMed ID: 22802682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribosome-inactivating Protein MAP30 Isolated from
    Zhou Y; Yang D; Qiang Z; Meng Y; Li R; Fan X; Zhao W; Meng Y
    Recent Pat Anticancer Drug Discov; 2024; 19(2):223-232. PubMed ID: 36330636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon.
    Lee-Huang S; Huang PL; Chen HC; Huang PL; Bourinbaiar A; Huang HI; Kung HF
    Gene; 1995 Aug; 161(2):151-6. PubMed ID: 7665070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Momordica charantia MAP30 and its antitumor effect on bladder cancer cells.
    Hlin H; Zhi-Guo Z; Cong-Hui H; Yan Z; Qing L; Bo J; Hou-Guang H; Jun-Jie Z; Pei-Ying Z
    Minerva Urol Nefrol; 2016 Jun; 68(3):275-81. PubMed ID: 25517785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of anti-HIV activity of anti-inflammatory drugs, dexamethasone and indomethacin, by MAP30, the antiviral agent from bitter melon.
    Bourinbaiar AS; Lee-Huang S
    Biochem Biophys Res Commun; 1995 Mar; 208(2):779-85. PubMed ID: 7695636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-HIV agent MAP30 modulates the expression profile of viral and cellular genes for proliferation and apoptosis in AIDS-related lymphoma cells infected with Kaposi's sarcoma-associated virus.
    Sun Y; Huang PL; Li JJ; Huang YQ; Zhang L; Huang PL; Lee-Huang S
    Biochem Biophys Res Commun; 2001 Oct; 287(4):983-94. PubMed ID: 11573962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mono-PEGylation of Alpha-MMC and MAP30 from Momordica charantia L.: Production, Identification and Anti-Tumor Activity.
    Sun Y; Sun F; Li J; Wu M; Fan X; Meng Y; Meng Y
    Molecules; 2016 Oct; 21(11):. PubMed ID: 27809255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant expression and purification of a MAP30-cell penetrating peptide fusion protein with higher anti-tumor bioactivity.
    Lv Q; Yang XZ; Fu LY; Lu YT; Lu YH; Zhao J; Wang FJ
    Protein Expr Purif; 2015 Jul; 111():9-17. PubMed ID: 25797209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of antiviral and antitumor proteins MAP30 and GAP31 in cucurbits using the plant virus vector ZYMV-AGII.
    Arazi T; Lee Huang P; Huang PL; Zhang L; Moshe Shiboleth Y; Gal-On A; Lee-Huang S
    Biochem Biophys Res Commun; 2002 Mar; 292(2):441-8. PubMed ID: 11906182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zirconium phosphatidylcholine-based nanocapsules as an in vivo degradable drug delivery system of MAP30, a momordica anti-HIV protein.
    Caizhen G; Yan G; Ronron C; Lirong Y; Panpan C; Xuemei H; Yuanbiao Q; Qingshan L
    Int J Pharm; 2015 Apr; 483(1-2):188-99. PubMed ID: 25681721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of recombinant ribosome inactivating protein MAP30 in E.coli and its biological activity].
    Zhang LL; Ding Q; Zhan JB
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 May; 39(3):264-71. PubMed ID: 20544988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel method for simultaneous production of two ribosome-inactivating proteins, α-MMC and MAP30, from Momordica charantia L.
    Meng Y; Lin S; Liu S; Fan X; Li G; Meng Y
    PLoS One; 2014; 9(7):e101998. PubMed ID: 25003606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of MDA-MB-231 human breast tumor xenografts and HER2 expression by anti-tumor agents GAP31 and MAP30.
    Lee-Huang S; Huang PL; Sun Y; Chen HC; Kung HF; Huang PL; Murphy WJ
    Anticancer Res; 2000; 20(2A):653-9. PubMed ID: 10810336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and purification of a recombinant ELRL-MAP30 with dual-targeting anti-tumor bioactivity.
    Chen WW; Zhang HR; Huang ZG; Zhou ZY; Lou QW; Jiang XY; Zhu ZH
    Protein Expr Purif; 2021 Sep; 185():105893. PubMed ID: 33933613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of a Recombinant Anti-HIV and Anti-Tumor Protein, MAP30, in Nicotiana tobacum Hairy Roots: A pH-Stable and Thermophilic Antimicrobial Protein.
    Moghadam A; Niazi A; Afsharifar A; Taghavi SM
    PLoS One; 2016; 11(7):e0159653. PubMed ID: 27459300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAP30 inhibits autophagy through enhancing acetyltransferase p300 and induces apoptosis in acute myeloid leukemia cells.
    Qian S; Sun L; Li J; Wu J; Hu G; Han Y; Yu K; Zhang S
    Oncol Rep; 2016 Jun; 35(6):3705-13. PubMed ID: 27035419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.